Clemex Technologies (CLMJF) 0.1205 $CLMJF
Clemex Discloses Third Quarter Results
ACCESSWIRE - Tue Mar 18, 10:24AM CDT
Net Profit of $200,042
Clemex Discloses Second Quarter Results. Net Profit of $55,237
ACCESSWIRE - Tue Dec 10, 1:40PM CST
Montreal, QC - December 10th, 2013-- Clemex Technologies Inc. (TSXV: CXG.A), designer and manufacturer of Image Analysis systems and software for microscopy applications, announces its financial results for the second Quarter of FY2014 ending October 31st, 2013. Sales reached $1,561,359 compared to $1,570,451 for the same period last year. The Corporation ends this quarter with a Net Profit of $55,716, and a Net Profit of $55,237 attributable to Clemex Technologies Inc. compared to a Net Profit of $101,047 posted last year. At mid-Fiscal year, the Corporation has accumulated a Net Loss of $211,658, and a Net Loss of $201,330 attributable to Clemex Technologies Inc., compared to a Net Profit of $56,782 for the same period last year.
Clemex's Presence at the "ACVP/ASVCP" Conference
ACCESSWIRE - Thu Nov 14, 2:07PM CST
Montreal, Quebec, November 14th, 2013 - Clemex Technologies Inc. (TSXV: CXG.A) announces that it will taking part at the "the American College of Veterinary Pathologists" conference which will be held at the Montreal Palais des Congres from November 16th to 20th 2013. Clemex will be presenting a new application developed for blood testing destined for use in the veterinary pathology industry. The animal health industry is growing and this market represents a business opportunity for the new automated microscopy instruments for hematology. Clemex has been developing this hematology instrument for a few years now and it can easily be adapted to the animal blood specific features.
Clemex Discloses First Quarter Results
ACCESSWIRE - Fri Sep 20, 1:34PM CDT
Montreal, QC - September 20th, 2013-- Clemex Technologies Inc. (TSXV: CXG.A), designer and manufacturer of Image Analysis systems and software for microscopy applications, announces its financial results for the first Quarter of FY2014 ending July 31st, 2013. Sales reached $1,042,744 compared to $1,305,152 for the same period last year. The Corporation ends this quarter with a Net Loss of $267,375, and a net loss of $256,567 attributable to Clemex Technologies compared to a net loss of $44,265 posted last year.
Clemex appoints a "Chief Operations Officer"
CNW Group - Mon Jan 21, 3:44PM CST
Symbol: CXG.A-CDNX www.clemex.com Shares Outstanding: 30,999,810
Clemex Discloses Third Quarter Results
ACCESSWIRE - Tue Mar 18, 10:24AM CDT
Net Profit of $200,042
Clemex Discloses Second Quarter Results. Net Profit of $55,237
ACCESSWIRE - Tue Dec 10, 1:40PM CST
Montreal, QC - December 10th, 2013-- Clemex Technologies Inc. (TSXV: CXG.A), designer and manufacturer of Image Analysis systems and software for microscopy applications, announces its financial results for the second Quarter of FY2014 ending October 31st, 2013. Sales reached $1,561,359 compared to $1,570,451 for the same period last year. The Corporation ends this quarter with a Net Profit of $55,716, and a Net Profit of $55,237 attributable to Clemex Technologies Inc. compared to a Net Profit of $101,047 posted last year. At mid-Fiscal year, the Corporation has accumulated a Net Loss of $211,658, and a Net Loss of $201,330 attributable to Clemex Technologies Inc., compared to a Net Profit of $56,782 for the same period last year.
Clemex's Presence at the "ACVP/ASVCP" Conference
ACCESSWIRE - Thu Nov 14, 2:07PM CST
Montreal, Quebec, November 14th, 2013 - Clemex Technologies Inc. (TSXV: CXG.A) announces that it will taking part at the "the American College of Veterinary Pathologists" conference which will be held at the Montreal Palais des Congres from November 16th to 20th 2013. Clemex will be presenting a new application developed for blood testing destined for use in the veterinary pathology industry. The animal health industry is growing and this market represents a business opportunity for the new automated microscopy instruments for hematology. Clemex has been developing this hematology instrument for a few years now and it can easily be adapted to the animal blood specific features.
Clemex Discloses First Quarter Results
ACCESSWIRE - Fri Sep 20, 1:34PM CDT
Montreal, QC - September 20th, 2013-- Clemex Technologies Inc. (TSXV: CXG.A), designer and manufacturer of Image Analysis systems and software for microscopy applications, announces its financial results for the first Quarter of FY2014 ending July 31st, 2013. Sales reached $1,042,744 compared to $1,305,152 for the same period last year. The Corporation ends this quarter with a Net Loss of $267,375, and a net loss of $256,567 attributable to Clemex Technologies compared to a net loss of $44,265 posted last year.
Clemex appoints a "Chief Operations Officer"
CNW Group - Mon Jan 21, 3:44PM CST
Symbol: CXG.A-CDNX www.clemex.com Shares Outstanding: 30,999,810
